Zion Market Research Global Oncology Adjuvants Market, 2016–2024 | Page 2

Oncology Adjuvants Market
Global Oncology Adjuvants Market: Overview
Oncology adjuvant treatment is a treatment for the cancer therapy, wherein which after the
primary treatment the cancer treatment is involved. The reoccurrence of the cancer is
minimized by the oncology adjuvants treatment. The oncology adjuvant therapy consists of
hormone therapy, chemotherapy, radiation therapy, targeted therapy, or biological therapy.
Before taking the option of the adjuvant therapy several factors need to be considered by
the oncologists such as the statistical data before opting for suitable. The chances of the
cancer patients surviving is more in this therapy. Many types of cancers can be treated with
the help of Oncology adjuvant therapy such as colon, prostate, lung, breast, and others
forms of gynecological cancers.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/oncology-
adjuvants-market
Global Oncology Adjuvants Market: Segmentation
The global market for oncology adjuvants is fragmented into its applications, indication, and
end user. According to the applications, the global market is segregated into chemotherapy,
hormone therapy, immunotherapy, targeted therapy, radiotherapy, and others. According to
the indication, the market is categorized into breast cancer, glioblastoma, lung cancer,
colorectal cancer, ovarian cancer, sarcoma, prostate cancer, and others. According to the
end user, the market is divided into cancer hospitals and cancer research institutes.